A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis

Chest - United States
doi 10.1016/j.chest.2016.02.641
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2017English

Serotonin‐Release Assay‐Negative Heparin‐Induced Thrombocytopenia

American Journal of Hematology
Hematology
2019English

HIT: Anti-Platelet Factor 4-Heparin (PF4-H) Assay Validation and Comparison Study

American Society for Clinical Laboratory Science
2019English

When Heparins Promote Thrombosis: Review of Heparin-Induced Thrombocytopenia

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

The Appropriateness of Testing Platelet Factor 4/Heparin Antibody in Patients Suspected of Heparin-Induced Thrombocytopenia

Cureus
2018English

A Case With Combined Multiple Retina Thrombosis Probably Due to Heparin-Induced Thrombocytopenia (HIT)

Nihon Toseki Igakkai Zasshi
2004English

Heparin-Induced Thrombocytopenia

Medicina
Medicine
2008English

Heparin-Induced Thrombocytopenia: A Prospective Study of 142 Patients

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
1985English

Heparin-Induced Thrombocytopenia (HIT)

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy